The Synthesis of Two Potent β-3 Adrenergic Receptor Agonists

被引:27
作者
Bradley, Paul A. [1 ]
Carroll, Robert J. [2 ]
Lecouturier, Yann C. [1 ]
Moore, Robert [2 ]
Noeureuil, Pierre [1 ]
Patel, Bhairavi [1 ]
Snow, Jonathan [2 ]
Wheeler, Simon [1 ]
机构
[1] Discovery Chem, Global Res & Dev, Sandwich CT13 9NJ, Kent, England
[2] Res API, Pfizer Global Res & Dev, Sandwich CT13 9NJ, Kent, England
关键词
POSSIBLE TOXIC ACTION; COMPUTER-PREDICTION; CHEMICAL-STRUCTURE; DEREK SYSTEM; REDUCTION; KETONES;
D O I
10.1021/op1001462
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
This contribution describes the initial preparation of two potent beta-3 receptor agonists 1 and 2. Subsequent scale up of these two compounds was required for further evaluation and proceeded via a common key amine intermediate 24. Synthesis of this key intermediate by way of a Ritter reaction was a vital step in the sequence. Enantioselective Noyori hydrogenation reactions gave access to the chiral epoxides necessary to make the target compounds. Chemistry was developed for the selective dehalogenation of the 2-chloropyridyl group in the presence of a sensitive isoxazole unit to provide access to 1.
引用
收藏
页码:1326 / 1336
页数:11
相关论文
共 16 条
[1]  
BROWN AD, 2004, Patent No. 2004108676
[2]   THERMAL-DECOMPOSITION OF 3-AMINO-5-METHYL ISOXAZOLE [J].
CARDILLO, P .
JOURNAL OF LOSS PREVENTION IN THE PROCESS INDUSTRIES, 1988, 1 (01) :46-47
[3]  
Dow R. L., 1997, EXPERT OPIN INV DRUG, P1354
[4]  
DOW RL, 2002, Patent No. 1236723
[5]   A scalable asymmetric synthesis of (R)-2-amino-1-(3-pyridinyl)ethanol dihydrochloride via an oxazaborolidine catalyzed borane reduction [J].
Duquette, J ;
Zhang, MB ;
Zhu, L ;
Reeves, RS .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2003, 7 (03) :285-288
[6]   Process for preparing Ezetimibe intermediate by an acid enhanced chemo- and enantioselective CBS catalyzed ketone reduction [J].
Fu, XY ;
McAllister, TL ;
Thiruvengadam, TK ;
Tann, CH ;
Su, D .
TETRAHEDRON LETTERS, 2003, 44 (04) :801-804
[7]  
IMARISHI M, 2008, J MED CHEM, V51, P1925
[8]   Discovery of potent and orally bioavailable heterocycle-based β3-adrenergic receptor agonists, potential therapeutics for the treatment of obesity [J].
Lafontaine, Jennifer A. ;
Day, Robert F. ;
Dibrino, Joe ;
Hadcock, John R. ;
Hargrove, Diane M. ;
Linhares, Michael ;
Martin, Kelly A. ;
Maurer, Tristan S. ;
Nardone, Nancy A. ;
Tess, David A. ;
DaSilva-Jardine, Paul .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) :5245-5250
[9]   Role of NaBH4 stabilizer in the oxazaborolidine-catalyzed asymmetric reduction of ketones with BH3-THF [J].
Nettles, SM ;
Matos, K ;
Burkhardt, ER ;
Rouda, DR ;
Corella, JA .
JOURNAL OF ORGANIC CHEMISTRY, 2002, 67 (09) :2970-2976
[10]   Computer prediction of possible toxic action from chemical structure: An update on the DEREK system [J].
Ridings, JE ;
Barratt, MD ;
Cary, R ;
Earnshaw, CG ;
Eggington, CE ;
Ellis, MK ;
Judson, PN ;
Langowski, JJ ;
Marchant, CA ;
Payne, MP ;
Watson, WP ;
Yih, TD .
TOXICOLOGY, 1996, 106 (1-3) :267-279